Tsfg, LLC Abbott Laboratories Transaction History

Tsfg, LLC

$487 Million
Q4 2024

A detailed history of Tsfg, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Tsfg, LLC holds 106,061 shares of ABT stock, worth $13.4 Million. This represents 2.46% of its overall portfolio holdings.

Number of Shares

106,061

Previous 94,225 12.56%

Holding current value

$13.4 Million

Previous $10.7 Million 11.67%

% of portfolio

2.46%

Previous 2.35%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 13, 2025	BUY	$111.93 - $119.39 $1.32 Million - $1.41 Million	11,836 Added 12.56%	106,061 $12 Million
Q3 2024 Oct 15, 2024	SELL	$100.07 - $118.13 $182,327 - $215,232	-1,822 Reduced 1.9%	94,225 $10.7 Million
Q2 2024 Jul 16, 2024	BUY	$100.73 - $112.44 $584,939 - $652,939	5,807 Added 6.44%	96,047 $9.98 Million
Q1 2024 Apr 16, 2024	SELL	$109.52 - $120.96 $985,570 - $1.09 Million	-8,999 Reduced 9.07%	90,240 $10.3 Million
Q4 2023 Jan 23, 2024	BUY	$90.19 - $110.4 $272,914 - $334,070	3,026 Added 3.15%	99,239 $10.9 Million
Q3 2023 Oct 10, 2023	BUY	$95.53 - $114.62 $450,423 - $540,433	4,715 Added 5.15%	96,213 $9.32 Million
Q2 2023 Jul 10, 2023	SELL	$100.78 - $112.29 $126,277 - $140,699	-1,253 Reduced 1.35%	91,498 $9.98 Million
Q1 2023 Apr 21, 2023	BUY	$96.86 - $114.01 $129,695 - $152,659	1,339 Added 1.46%	92,751 $9.39 Million
Q4 2022 Jan 19, 2023	BUY	$95.06 - $111.52 $233,372 - $273,781	2,455 Added 2.76%	91,412 $10 Million
Q3 2022 Oct 20, 2022	BUY	$96.76 - $112.03 $496,378 - $574,713	5,130 Added 6.12%	88,957 $8.61 Million
Q2 2022 Jul 13, 2022	SELL	$102.07 - $123.37 $24,394 - $29,485	-239 Reduced 0.28%	83,827 $9.11 Million
Q1 2022 Apr 25, 2022	SELL	$114.02 - $139.04 $145,945 - $177,971	-1,280 Reduced 1.5%	84,066 $9.95 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $909,914 - $1.11 Million	7,876 Added 10.17%	85,346 $12 Million
Q3 2021 Oct 12, 2021	BUY	$116.66 - $129.06 $339,597 - $375,693	2,911 Added 3.9%	77,470 $9.15 Million
Q2 2021 Jul 19, 2021	BUY	$105.79 - $124.53 $275,159 - $323,902	2,601 Added 3.61%	74,559 $8.64 Million
Q1 2021 Apr 14, 2021	BUY	$108.84 - $128.23 $200,918 - $236,712	1,846 Added 2.63%	71,958 $8.62 Million
Q4 2020 Jan 20, 2021	BUY	$105.0 - $114.42 $6,405 - $6,979	61 Added 0.09%	70,112 $7.68 Million
Q3 2020 Oct 06, 2020	BUY	$91.64 - $111.29 $1.69 Million - $2.06 Million	18,496 Added 35.88%	70,051 $7.62 Million
Q2 2020 Jul 07, 2020	BUY	$76.57 - $98.0 $328,638 - $420,616	4,292 Added 9.08%	51,555 $4.71 Million
Q1 2020 Apr 08, 2020	BUY	$62.82 - $91.86 $284,134 - $415,482	4,523 Added 10.58%	47,263 $3.73 Million
Q4 2019 Jan 27, 2020	BUY	$78.51 - $87.4 $300,222 - $334,217	3,824 Added 9.83%	42,740 $3.71 Million
Q3 2019 Jan 27, 2020	BUY	$81.84 - $88.74 $796,303 - $863,440	9,730 Added 33.34%	38,916 $3.26 Million
Q2 2019 Jan 27, 2020	BUY	$72.88 - $85.0 $422,558 - $492,830	5,798 Added 24.79%	29,186 $2.45 Million
Q1 2019 Jan 27, 2020	BUY	$66.22 - $80.06 $1.55 Million - $1.87 Million	23,388 New	23,388 $1.87 Million

Others Institutions Holding ABT

# of Institutions

3,378

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $222B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.

Account